Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 155
- −21 vs. Q4 2025
- Portfolio value
- $4.20B
- −$1.07B (−20.4%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| QGENQiagen N.V. | ORD SHARES | 243 | $9.73K | <0.1% | +243 | New | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 4,627 | $14.2K | <0.1% | −294−6.0% | Reduced | History |
| QCOMQualcomm Inc | Stock | 197 | $25.4K | <0.1% | −12−5.7% | Reduced | History |
| DGXQuest Diagnostics Inc | COM | 131 | $25.7K | <0.1% | −7,149−98.2% | Reduced | History |
| ORCLOracle Corp | Stock | 191 | $28.1K | <0.1% | −12−5.9% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 5,261 | $38.1K | <0.1% | −1,485,257−99.6% | Reduced | History |
| MTDMettler Toledo International Inc | COM | 36 | $45.4K | <0.1% | −2−5.3% | Reduced | History |
| INCYIncyte Corp | COM | 486 | $45.7K | <0.1% | −4,287−89.8% | Reduced | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 6,982 | $62.5K | <0.1% | +6,982 | New | History |
| ZTSZoetis Inc. | Stock | 533 | $63.0K | <0.1% | −196−26.9% | Reduced | History |
| MSFTMicrosoft Corp | Stock | 172 | $63.7K | <0.1% | −1,110−86.6% | Reduced | History |
| NVDANVIDIA Corp | Stock | 408 | $71.2K | <0.1% | −3,525−89.6% | Reduced | History |
| LHLabcorp Holdings Inc. | Stock | 280 | $74.7K | <0.1% | −5,389−95.1% | Reduced | History |
| AAgilent Technologies, Inc. | COM | 664 | $75.7K | <0.1% | +314+89.7% | Added | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 1,016 | $88.4K | <0.1% | −6,488−86.5% | Reduced | History |
| GOOGLAlphabet Inc. | Stock | 314 | $90.3K | <0.1% | −1,752−84.8% | Reduced | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,545 | $96.9K | <0.1% | −10,005−86.6% | Reduced | History |
| CAICaris Life Sciences, Inc. | COM | 6,418 | $114.8K | <0.1% | 00.0% | Unchanged | History |
| ABVXAbivax S.A. | SPONSORED ADS | 1,048 | $116.7K | <0.1% | +1,048 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 536 | $122.6K | <0.1% | −23,794−97.8% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 740 | $126.2K | <0.1% | −40,527−98.2% | Reduced | History |
| PTCTPTC Therapeutics, Inc. | COM | 1,935 | $131.8K | <0.1% | −4,828−71.4% | Reduced | History |
| CAHCardinal Health Inc | Stock | 863 | $182.4K | <0.1% | −6,806−88.7% | Reduced | History |
| TEMTempus AI, Inc. | CL A | 4,950 | $223.8K | <0.1% | +174+3.6% | Added | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 5,016 | $238.6K | <0.1% | +3,136+166.8% | Added | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 16,443 | $245.2K | <0.1% | +12,541+321.4% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 3,857 | $249.3K | <0.1% | +3,857 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 8,899 | $264.4K | <0.1% | +5,072+132.5% | Added | History |
| AMZNAmazon Com Inc | Stock | 1,353 | $281.8K | <0.1% | −2,188−61.8% | Reduced | History |
| ADBEAdobe Inc. | Stock | 1,200 | $291.7K | <0.1% | 00.0% | Unchanged | History |
| ACNAccenture plc | Stock | 1,500 | $297.4K | <0.1% | 00.0% | Unchanged | History |
| SMMTSummit Therapeutics Inc. | COM | 15,858 | $300.7K | <0.1% | +1,596+11.2% | Added | History |
| GRMNGarmin Ltd | SHS | 1,321 | $306.5K | <0.1% | −405−23.5% | Reduced | History |
| ALKSAlkermes plc. | SHS | 8,870 | $313.6K | <0.1% | +2,276+34.5% | Added | History |
| JDJD.com, Inc. | SPON ADS CL A | 11,000 | $325.3K | <0.1% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 6,803 | $327.9K | <0.1% | −138,364−95.3% | Reduced | History |
| DNLIDenali Therapeutics Inc. | COM | 17,766 | $341.1K | <0.1% | +10,628+148.9% | Added | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 9,030 | $358.7K | <0.1% | +9,030 | New | History |
| VVisa Inc. | Stock | 1,400 | $423.1K | <0.1% | 00.0% | Unchanged | History |
| BLKBlackRock, Inc. | Stock | 450 | $432.8K | <0.1% | 00.0% | Unchanged | History |
| AGMBAgomAb Therapeutics NV | SPONSORED ADS | 50,000 | $524.5K | <0.1% | +50,000 | New | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 5,750 | $527.7K | <0.1% | −9,750−62.9% | Reduced | – |
| AXSMAxsome Therapeutics, Inc. | COM | 3,181 | $537.7K | <0.1% | −24,419−88.5% | Reduced | History |
| CORCencora, Inc. | Stock | 1,716 | $539.1K | <0.1% | +1,195+229.4% | Added | History |
| MAMastercard Inc | Stock | 1,100 | $549.6K | <0.1% | 00.0% | Unchanged | History |
| PGProcter & Gamble Co | Stock | 3,900 | $563.3K | <0.1% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 1,757 | $566.1K | <0.1% | +1,757 | New | History |
| CERTCertara, Inc. | COM | 99,442 | $566.8K | <0.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 8,841 | $582.7K | <0.1% | −384−4.2% | Reduced | History |
| BABAAlibaba Group Holding Ltd | ADR | 4,700 | $589.7K | <0.1% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 4,646 | $612.1K | <0.1% | −1,698,658−99.7% | Reduced | History |
| CSCOCisco Systems, Inc. | Stock | 8,000 | $620.7K | <0.1% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 35,886 | $649.2K | <0.1% | −28,085−43.9% | Reduced | History |
| BIIBBiogen Inc. | COM | 3,653 | $669.7K | <0.1% | +88+2.5% | Added | History |
| BBNXBeta Bionics, Inc. | COM | 72,152 | $723.0K | <0.1% | −133−0.2% | Reduced | History |
| SHELShell plc | ADR | 7,844 | $729.5K | <0.1% | +7,844 | New | History |
| BPBP PLC | ADR | 15,644 | $735.3K | <0.1% | +15,644 | New | History |
| XOMExxonMobil Holdings Corp | COM | 4,370 | $741.4K | <0.1% | +4,370 | New | History |
| EQNREquinor ASA | SPONSORED ADR | 17,573 | $741.6K | <0.1% | +17,573 | New | History |
| MLYSMineralys Therapeutics, Inc. | COM | 29,374 | $795.7K | <0.1% | +9,548+48.2% | Added | History |
| BLLNBillionToOne, Inc. | CL A | 10,554 | $833.1K | <0.1% | −35−0.3% | Reduced | History |
| AAPLApple Inc. | Stock | 3,320 | $842.6K | <0.1% | 00.0% | Unchanged | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 27,661 | $885.4K | <0.1% | −8,675−23.9% | Reduced | History |
| EHCEncompass Health Corp | COM | 9,829 | $950.8K | <0.1% | −9,260−48.5% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 17,038 | $1.03M | <0.1% | −50,044−74.6% | Reduced | History |
| ADPTAdaptive Biotechnologies Corp | COM | 76,181 | $1.06M | <0.1% | −221,909−74.4% | Reduced | History |
| PHRPhreesia, Inc. | COM | 130,992 | $1.10M | <0.1% | −52,221−28.5% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 3,812 | $1.13M | <0.1% | +1,922+101.7% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 2,077 | $1.23M | <0.1% | −1,818−46.7% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 14,447 | $1.52M | <0.1% | −2,096−12.7% | Reduced | History |
| MASIMasimo Corp | COM | 8,753 | $1.56M | <0.1% | −88,532−91.0% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 3,040 | $1.59M | <0.1% | +156+5.4% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 10,034 | $1.64M | <0.1% | −3,881−27.9% | Reduced | History |
| SPYSPDR S&P 500 ETF Trust | ETF | 2,700 | $1.76M | <0.1% | −400−12.9% | Reduced | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 38,296 | $1.84M | <0.1% | +25,095+190.1% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 20,851 | $1.85M | <0.1% | −22,904−52.3% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 25,377 | $1.88M | <0.1% | +1,266+5.3% | Added | History |
| OMDAOmada Health, Inc. | COM | 157,938 | $1.99M | <0.1% | −19,959−11.2% | Reduced | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 115,590 | $2.30M | 0.1% | −165−0.1% | Reduced | History |
| ILMNIllumina, Inc. | COM | 20,223 | $2.49M | 0.1% | −2,717−11.8% | Reduced | History |
| PFEPfizer Inc | Stock | 107,635 | $3.02M | 0.1% | +50,788+89.3% | Added | History |
| RNAAtrium Therapeutics, Inc. | COM | 263,096 | $3.52M | 0.1% | +263,096 | New | History |
| PENPenumbra Inc | COM | 12,267 | $4.03M | 0.1% | −123,128−90.9% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 226,703 | $4.66M | 0.1% | −221,460−49.4% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 99,735 | $5.14M | 0.1% | −1,026−1.0% | Reduced | History |
| MDLNMedline Inc. | COM CL A | 136,635 | $6.08M | 0.1% | +18,915+16.1% | Added | History |
| WAYWaystar Holding Corp. | COM | 256,139 | $6.18M | 0.1% | +14,405+6.0% | Added | History |
| NTRANatera, Inc. | COM | 31,694 | $6.34M | 0.2% | −24,342−43.4% | Reduced | History |
| CVSCVS Health Corp | Stock | 89,363 | $6.42M | 0.2% | −19,695−18.1% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 329,492 | $7.00M | 0.2% | +7,432+2.3% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 38,269 | $7.22M | 0.2% | −1,970−4.9% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 250,082 | $7.53M | 0.2% | −77,781−23.7% | Reduced | History |
| CNCCentene Corp | Stock | 261,066 | $8.55M | 0.2% | −12,608−4.6% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 56,517 | $9.93M | 0.2% | −24,012−29.8% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 101,139 | $10.1M | 0.2% | +3,254+3.3% | Added | History |
| HUMHumana Inc | Stock | 64,498 | $11.2M | 0.3% | −8,583−11.7% | Reduced | History |
| LIVNLivaNova PLC | SHS | 186,185 | $11.8M | 0.3% | +186,185 | New | History |
| PRCTPROCEPT BioRobotics Corp | COM | 502,286 | $12.6M | 0.3% | −13,144−2.6% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 155,571 | $14.1M | 0.3% | −83,109−34.8% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 52,518 | $15.4M | 0.4% | −17,127−24.6% | Reduced | History |
Sold out since Q4 2025 (40)
Positions held at the end of Q4 2025 that are gone from this filing.
| Security | Class | Shares in Q4 2025 | Value in Q4 2025 | % of portfolio in Q4 2025 | History |
|---|---|---|---|---|---|
| Avidity Biosciences, Inc.05370A108 | COM | 2,630,969 | $189.8M | 3.6% | – |
| FOLDAmicus Therapeutics, Inc. | COM | 10,735,195 | $152.9M | 2.9% | History |
| MAZEMaze Therapeutics, Inc. | COM | 887,708 | $36.8M | 0.7% | History |
| CDNACareDx, Inc. | COM | 431,070 | $8.12M | 0.2% | History |
| MOHMolina Healthcare, Inc. | COM | 46,626 | $8.09M | 0.2% | History |
| ICLRIcon PLC | COM | 24,560 | $4.48M | 0.1% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 65,008 | $3.86M | 0.1% | History |
| BTSGBrightSpring Health Services, Inc. | COM | 92,095 | $3.45M | 0.1% | History |
| NEONeogenomics Inc | COM NEW | 278,286 | $3.27M | 0.1% | History |
| AVTRAvantor, Inc. | COM | 276,266 | $3.17M | 0.1% | History |
| BEAMBeam Therapeutics Inc. | COM | 111,510 | $3.09M | 0.1% | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 30,431 | $2.80M | 0.1% | History |
| VKTXViking Therapeutics, Inc. | COM | 68,665 | $2.42M | <0.1% | History |
| ROIVRoivant Sciences Ltd. | SHS | 108,039 | $2.34M | <0.1% | History |
| BKDBrookdale Senior Living Inc. | COM | 167,444 | $1.81M | <0.1% | History |
| SIBNSI-BONE, Inc. | COM | 90,331 | $1.78M | <0.1% | History |
| EXASExact Sciences Corp | COM | 16,062 | $1.63M | <0.1% | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 142,243 | $981.5K | <0.1% | History |
| ANETArista Networks, Inc. | Stock | 4,800 | $628.9K | <0.1% | History |
| iShares Russell 2000 ETF464287655 | ETF | 2,300 | $566.2K | <0.1% | – |
| METAMeta Platforms, Inc. | Stock | 800 | $528.1K | <0.1% | History |
| DOCSDoximity, Inc. | CL A | 11,817 | $523.3K | <0.1% | History |
| LULUlululemon athletica inc. | Stock | 2,240 | $465.5K | <0.1% | History |
| PLTRPalantir Technologies Inc. | Stock | 2,500 | $444.4K | <0.1% | History |
| CORTCorcept Therapeutics Inc | COM | 10,495 | $365.2K | <0.1% | History |
| PLNTPlanet Fitness, Inc. | CL A | 3,173 | $344.2K | <0.1% | History |
| EXELExelixis, Inc. | COM | 7,361 | $322.6K | <0.1% | History |
| GHGuardant Health, Inc. | COM | 3,004 | $306.8K | <0.1% | History |
| SNYSanofi | SPONSORED ADR | 5,851 | $283.5K | <0.1% | History |
| MRNAModerna, Inc. | Stock | 7,711 | $227.4K | <0.1% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 4,942 | $170.8K | <0.1% | History |
| CGONCG Oncology, Inc. | COM | 3,095 | $128.5K | <0.1% | History |
| QUREuniQure N.V. | SHS | 4,763 | $114.0K | <0.1% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 4,210 | $105.8K | <0.1% | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 7,913 | $99.7K | <0.1% | History |
| TRVITrevi Therapeutics, Inc. | COM | 7,603 | $95.2K | <0.1% | History |
| GMABGenmab A/S | SPONSORED ADS | 3,009 | $92.7K | <0.1% | History |
| TYRATyra Biosciences, Inc. | COM | 3,143 | $82.6K | <0.1% | History |
| ORICOric Pharmaceuticals, Inc. | COM | 9,706 | $79.4K | <0.1% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 2,978 | $26.8K | <0.1% | History |